GVR Report cover Prefilled Syringes Market Size, Share & Trends Report

Prefilled Syringes Market Size, Share & Trends Analysis Report By Distribution Channel, By Type (Disposable, Reusable), By Material (Plastic, Glass), By Application (Diabetes, Anaphylaxis), And Segment Forecasts, 2018 - 2025

  • Published Date: Jun, 2018
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-309-6
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 80

Industry Insights

The global prefilled syringes market size was valued at USD 8.6 billion in 2016 and is projected to expand at a CAGR of 11.2% over the forecast period. Growing demand for efficient and easy-to-use drug delivery devices and increasing efforts of healthcare professionals to reduce human errors in drug delivery errors are the key growth-driving factors for the market.

Japan prefilled syringes market

The fast-paced development of feature-rich devices with underlying technological advancements enabling safer and convenient self-injections is expected to fuel the market growth during the forecast period. Prefilled syringes help healthcare practitioners in saving time and effort while preparing injection doses. In addition, they help reduce the manual and device-based measuring errors and wastage of active pharmaceutical ingredients while transferring solutions from vials to syringe.

Advancement in the biopharmaceutical industry has a direct positive impact on the demand for prefilled syringes as they help minimize the loss of potency while transferring biopharmaceuticals in different containers. Some of the biological drugs that are preferably packed in prefilled syringes include small, as well as large, molecules such as antibody drug conjugates and monoclonal antibodies.

On the other hand, the regulated production of plastic syringes is challenging the market growth. The adverse effects of plastic products on the environment are also limiting the adoption of these devices. However, major companies in the field are trying to develop advanced materials that are disposable, recyclable, and suitable for containing injectable drugs. This factor is anticipated to augment market growth in the near future.

Type Insights

The disposable segment led the global market in 2016 and is expected to remain dominant throughout the forecast years owing to its wide applications. High preference for patient safety has resulted in increased usage of disposable devices in hospitals and homecare settings. Moreover, these devices reduce contamination risks, which is also projected to boost their demand.

On the other hand, the reusable segment is expected to register the fastest growth rate during the forecast period. The development of advanced auto-injectors, such as i-Pen by Haselmeier AG and VigiPen by VigiHealth, has augmented the segment growth.

Material Insights

Based on materials, the market is segmented into glass and plastic. Glass products led the market in 2016. However, the plastic segment is expected to be the dominant segment during the later phase of the forecast period and dominate with a larger revenue share in 2025.

Clarity and inertness offered by plastic-based products is the major factor driving the segment’s growth. These properties also increase the level of safety by maintaining the purity of stored drug dosage. In addition, plastic prefilled syringes reduce the overall cost of the dose, which is also likely to fuel their demand.

Application Insight

Diabetes captured the largest market share in 2016. The growing prevalence of the disease and the need for effective and safer insulin delivery devices are the factors augmenting the segment development. The diabetes segment is followed by the anaphylaxis segment.

Public awareness campaigns and price discrimination approach implemented by Mylan N.V. for its patent-protected device called EpiPen, which is an epinephrine injection, is resulting in the growth of the anaphylaxis application segment.

Prefilled products serve as a great tool for the storage of vaccines and other biotech drugs, which are unstable and are prone to change their properties while transferring from vials. Recently the U.S. FDA approved Auvi Q by Kaléo. This device is intended for use in life-threatening allergic reactions in infants and children.

Distribution Channel Insights

These devices are used in the emergency, as well as surgery, rooms to save time and avoid errors during emergency treatments. However, with the availability of affordable syringes, the use of prefilled syringes is increasing in regular OPDs. These products have enabled cost saving by minimizing the wastage of APIs during the dose preparation process to a great extent. Thus, costly drugs are mostly administered through these devices, which are filled precisely using automated machines.

The hospital segment holds the largest share of the global market. However, the growing trend of self-care due to the easy availability of advanced devices that reduce the visits to healthcare professionals is expected to have a negative impact on the growth of this segment.

Global prefilled syringes market

Mail order pharmacies help serve patients suffering from chronic conditions such as diabetes and anaphylaxis. Subscriptions to mail order pharmacies are preferred mostly by patients who need to take regular doses by injection. This helps in reducing the total cost incurred to the patient during the course of therapy. Products sold through this channel are required to be designed with utmost patient convenience,.

Regional Insights

Europe is currently dominating the global market owing to the growing demand for prefilled syringes in the region. Moreover, the strong presence of major market players such as Gerresheimer AG, Schott Group, and Owen Mumford Ltd. is also likely to help boost the region’s growth.

The European Board of Anesthesiology recommends the use of prefilled syringes for anesthesia. Increasing number of surgeries due to various factors and faster approval procedures by various regulatory authorities are the factors expected to drive the Europe regional market.

The Asia Pacific market is expected to grow at a lucrative CAGR during the forecast period. Rapidly developing economies, such as India and China, and the availability of untapped growth opportunities are the key factors fueling the region’s expansion. Moreover, a large patient population and the growing prevalence of various chronic diseases are expected to fuel the sector growth in the region.

Prefilled Syringes Market Share Insights

Some of the key players in the global market are Gerresheimer AG, Schott Group, Unilife Corporation, Nipro Medical Corporation, Owen Mumford, and Haselmeier AG. These companies focus on deploying investments to increase their manufacturing capabilities and hence maintain their revenue share.

In addition, the growing demand for these products is attracting new market entrants to provide contract services for the filling of syringes. New entrants are also focusing on developing improved designs with advanced drug filling technologies, which is projected to help spur market growth.

Report Scope



Base year for estimation



Actual estimates/Historical data


2014 - 2015

Forecast period


2016 - 2025

Market representation

Revenue in USD Million & CAGR from 2016 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage  

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global prefilled syringes market report on the basis of type, material, application, distribution channel, and region:

  • Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Disposable

    • Reusable

  • Material Outlook (Revenue, USD Million, 2014 - 2025)

    • Glass

    • Plastic

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Anaphylaxis

    • Rheumatoid Arthritis

    • Diabetes

    • Others

      • Vaccines and Other Biotech Drugs

  • Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

    • Hospitals

    • Mail Order Pharmacies

    • Ambulatory Surgery Centers

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • India

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.